• National Update: COVID

    • Share:
    July 27, 2020
    President Trump is leading a once-in-a-generation effort to ensure Americans have swift access to a safe COVID-19 vaccine. Today, President Trump traveled to North Carolina to tour Bioprocess Innovation Center at Fujifilm Diosynth Biotechnologies, a plant where key components of potential vaccines are being produced. Following the tour, President Trump delivered remarks on cutting bureaucratic red tape and the collaboration between his Administration and the private sector to rapidly develop a vaccine for COVID-19. More information on President Trump’s efforts regarding vaccines can be found below and here.
    President Trump is harnessing the full power of the public and private sectors to deliver a safe and effective vaccine as soon as possible.
    • Earlier this year, President Trump launched Operation Warp Speed, a groundbreaking partnership between the Federal Government, scientific community, and private sector to develop and deliver vaccines in record time.
      • Operation Warp Speed’s goal is to produce and deliver 300 million doses of safe and effective vaccines with the initial doses available by January 2021.
    • The Administration has made large investments in multiple vaccine candidates to provide financial infrastructure for mass manufacturing, in parallel with late-stage clinical trials.
    The President’s strategy for safely expediting vaccine development is already achieving incredible results.
    • Operation Warp Speed has invested in more than five vaccines and teamed up with multiple pharmaceutical companies to safely produce as many effective vaccines as possible.
    • A number of vaccine candidates have shown promising early clinical results and are either in or starting Phase 3 clinical trials, including AstraZeneca, Moderna, and Pfizer.
    • Several vaccine candidates are using the National Institutes of Health (NIH) clinical trial network to help enroll individuals into the clinical trials.
    President Trump has unleashed the power of American innovation in order to fight the invisible enemy.
    • The United States has conducted over 52 million tests, produced thousands of ventilators each month, and distributed 100 million N95 masks, 35 million surgical masks, and 15 million face shields.
    • The Food and Drug Administration (FDA) has authorized more than 185 tests under emergency authorities, including more than 150 molecular tests and 30 antibody tests.
    • The FDA launched its Coronavirus Treatment Acceleration Program to facilitate new treatments for COVID-19 patients as quickly as possible.
    • A number of promising therapies for COVID-19, like Remdesivir, have been identified and are already in use.